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INTRODUCTION
There are an estimated 101,200 people living with HIV in the UK of whom 13% have not yet been diagnosed and are unaware of their infection [1] . A similar percentage are found in other, socioeconomic equivalent countries [2, 3] . Two thirds of new infections are likely to be transmitted from those unaware of their HIV status [4] . Treatment for HIV infection using antiretroviral treatment (ART) is highly effective but early and prompt diagnosis of infection are paramount for greatest benefit of treatment. Recent international recommendations now state that ART should be initiated in all individuals with HIV infection irrespective of CD4 cell count [5, 6] . Late diagnosis of HIV is common in Europe with 48% of HIV infected persons presenting with a CD4 cell count <350 cells/mm 3 and 28% with CD4 count < 200 cells/mm 3 in 2015 [7] . Late diagnosis is also a problem globally [8] . In England during 2015, 39% of adults newly diagnosed with HIV were diagnosed late (CD4 count < 350 mm 3 ) [9] . In areas of high prevalence (>2 per 1000 among 15-59-year old's), the British HIV Association (BHIVA) national guidelines recommend that all new general practice registrants and all new hospital admissions should be tested for HIV [10] . In the USA, current guidance is for routine testing among all adults that come into contact with the healthcare system [11] . Patients often present to healthcare professionals (HCPs) with symptoms or conditions that are associated with HIV called HIV indicator conditions (HIV ICs). HIV ICs are diseases and symptoms that have been associated with underlying HIV infection of which 37 HIV ICs have been documented [10] . In the primary care setting general practitioners (GP) are recommended to follow an indicator condition-guided testing approach [10, 12] . All patients presenting with any HIV IC in primary care should be offered an HIV test. Research shows that often the GP or HCP are unfamiliar with HIV ICs and do not associate these conditions with HIV infection resulting in potential HIV diagnoses being missed [13, 14] . There is the added complication that a high proportion of these conditions are nonspecific in nature and some symptoms resemble more mundane infections for which patients may often not seek medical advice. During the early stages of primary HIV infection (PHI) or acute retroviral syndrome (ARS) symptoms usually develop within 2 to 4 weeks after infection. Symptoms or seroconversion illness may be present in 23% to 92% of infected cases [15] . Typical symptoms include fever, fatigue, rash, nausea and headache that usually last 2 to 3 weeks and often represent the only clinical signs of HIV infection until many years later when more advanced immunosuppression may occur. Many other diverse clinical conditions may also present with these symptoms [16] . Earlier diagnosis of HIV therefore requires innovative strategies to target testing towards individuals most likely to be infected.
IC guided testing provides a valuable opportunity to identify individuals with undiagnosed HIV infection. A recent study showed that 27% of patients had presented for care at least once with HIV and/or AIDS associated conditions 3 years prior to receiving their diagnosis [17] . Because HCPs decide whether a test offer is appropriate based on the patient's symptoms and not on race, ethnicity or sexuality, IC guided testing is less stigmatising. IC guided testing also removes the need for individual risk assessment and helps to normalise testing [18] . However, there is still a compelling need to educate clinicians and GPs about HIV and incorporating IC guided testing [19] in order to decrease rates of late diagnosis. A recent review of newly infected HIV patients in Germany found that ICs were present in one fifth of late presenters [20] . Scognamiglio et al. found that approximately 30% of newly diagnosed adults with HIV infection had reported at least one IC before HIV diagnosis and that having an HIV test within 6 months of being diagnosed with an indicator disease reduced the risk of late presentation by 50%. The HIV Indicator Diseases Across Europe Study (HIDES) [21] has raised awareness of IC based testing and developed an indicator disease testing strategy in which patients were tested routinely for HIV if presenting with preselected ICs (HIDES I & II studies) [22, 23] . Data from the HIDES II audit in patients accessing care for a number of HIV ICs highlighted that testing rates in those with ICs remained low across Europe [23] with poor adherence to European guidelines recommending routine testing [21] . High HIV positivity rates were observed in individuals with AIDS defining and non-AIDS defining ICs within the HIDES study [23] and have also been reported in other studies [24] . Therefore, interventions are needed that prompt HCPs to offer a test when patients present with HIV ICs.
We review data on the most commonly reported HIV ICs found in or associated with either acute or chronic HIV infection in individuals prior to or at HIV diagnosis. In addition, we review research studies of interventions that have used HIV ICs to guide/ increase HIV testing and explore which of these interventions have been most effective in increasing HIV testing rates and case finding. Our review may aid policy makers and HCPs in developing strategies to improve and increase HIV testing in individuals that present with defined HIV ICs, and show the potential of ICs as effective triggers for HIV testing that should decrease late diagnosis.
MATERIALS AND METHODS

Search Strategy
We carried out a broad literature search of published documents that included peer reviewed articles in journals, reports and British HIV Association (BHIVA) conference proceedings. The following electronic databases were searched; OVID Medline, Google, Web of Science and PubMed. The search was last performed on 15 th November 2016. We used a combination of focused computerised retrieval and hand searching. Hand searching involved manual page by page examination of recent BHIVA conference proceedings to identify eligible studies (abstracts from 2010 to 2017).
We also manually searched reference lists of relevant articles for additional publications. 
Selected Studies
Papers included in the review had to meet the following inclusion criteria: studies conducted in high income countries that had investigated associations of ICs with HIV infection among adult populations (>18 years of age) and interventions that had used ICs to guide HIV testing published in the combination ART era . Documents had to be accessible through the University of Bristol institutional library service. We excluded studies relating to HIV testing or screening of pregnant women and HIV infection in children.
RESULTS
Associations of HIV Indicator Conditions (HIV ICs) with HIV Infection
Characteristics of studies
The review found 42 studies which investigated associations of ICs with testing positive for HIV infection (Table 1) . Of these, 37 studied individuals prior to or after diagnosis, and 5 only studied signs and symptoms in individuals specifically diagnosed with acute HIV infection (AHI)/primary HIV infection (PHI).
Studies included in this analysis were: peer reviewed papers (n= 35) abstracts from BHIVA conference proceedings (n= 7). Locations of included studies were: UK and Northern Ireland (n=14), France (n= 1), Italy (n= 1), Germany (n= 1), Spain (n=4), Sweden (n=1), Switzerland (n=1), Amsterdam (n=1), Denmark (n=2), Europe wide (n=4), Japan (n=1), Canada (n=1), USA (n= 7), Brazil (n=1), Worldwide (n = 2). Studies used a variety of different data collection methods including: cross sectional analysis (n= 4), prospective analysis (n= 6), retrospective analysis (n=19), retrospective/audit (n = 4), case note review (n=2), case/control studies (n=3), service evaluation (n=1), observational study (n=1) and information gathered from review articles (n= 2). Studies were carried out in the following settings: primary care (n= 8), secondary care (n= 17), both primary and secondary care settings (n=1), sexual health clinic & secondary care (n= 2), sexual health clinics (n=5), HIV and medical centres (n= 6), public health surveillance database (n= 1), collection of different settings (e.g reviews) (n= 2).
Most commonly reported HIV indicator conditions (HIV ICs) and strongest associations of ICs with HIV infection
A list was compiled of over 110 HIV ICs and symptoms reported across 42 studies which included approximately 105,500 HIV positive patients either prior to or after receiving a diagnosis of HIV. These studies were carried out across different healthcare settings ( Table 1) . The most commonly reported HIV-related conditions were; pneumonia and bacterial pneumonia (24 studies), herpes zoster (17 studies), oral candidiasis and oesophageal candidiasis (14 studies), STIs (in general) (14 studies), seborrhoeic dermatitis (12 studies), tuberculosis and pulmonary tuberculosis (8 studies), Kaposi sarcoma (8 studies), blood dyscrasia (7 studies) and thrombocytopenia (7 studies). The most common symptoms were diarrhoea (11 studies), fever/pyrexia (14 studies), weight loss (14 studies), and lymphadenopathy (17 studies).
The healthcare setting in which the HIV ICs were identified is an important factor when considering the prevalence of each condition/disease. Some diseases are more likely to be diagnosed and treated in the primary care setting e.g. herpes zoster. However, compared to patients seen in general practice, those who need to be hospitalised are likely to present with more complex conditions associated with immunosuppression. Figs. 1 to 7 show some of the most commonly reported HIV ICs and the prevalence estimates reported for each IC by healthcare setting (primary, secondary or tertiary care), using studies with available data.
To present results of our review of the most common reported HIV ICs we have grouped diseases into symptoms seen in PHI/AHI, STIs and blood borne viruses (BBVs), conditions associated with immunosuppression and cancers and finally other common conditions and symptoms.
Primary HIV infection
In the studies that analysed patients with PHI or AHI, the most commonly reported conditions/symptoms were fever/pyrexia of unknown origin, lymphadenopathy, rash, headache, weight loss and gastrointestinal symptoms (nausea, vomiting, diarrhoea). Lymphadenopathy was a condition commonly found in individuals reported as having PHI or AHI [25] [26] [27] [28] . Strong associations of the presence of lymphadenopathy with PHI/AHI were reported in the following review articles; lymphadenopathy was present in 7-75% of patients with AHI [27] , odds ratio of early HIV infection (versus uninfected) in those reporting lymphadenopathy was 4.6 (95% CI 1. [3] [4] [5] [6] [7] [8] and the presence of lymphadenopathy was the most useful sign to indicate an individual with early HIV infection [28] . Other studies also showed that lymphadenopathy or swollen glands were common symptoms in individuals with PHI: 45% [25] and 21% [26] .
Fever/pyrexia was also a commonly reported symptom in PHI or AHI; in individuals infected with HIV (91% were MSM) 55% had reported symptoms of fever [26] and among patients with AHI it was 77% [29] . In a review article by Richey & Halperin (2013) , between 53-90% of patients presented with fever and in a multivariable analysis of individuals with PHI, fever (OR 5.2, 95% CI 2.3-11.7) and rash (OR 4.8, 95% CI 2.4-9.8) were the symptoms most strongly associated with PHI and indicated the highest risk of HIV infection [30] . Other conditions and symptoms commonly seen in individuals with PHI /AHI are listed in Table 1 alongside the study references.
Sexually transmitted infections (STIs) and Blood Born viruses (BBVs)
STIs and BBVs most commonly reported either prior to or at HIV diagnosis were; Hepatitis C (9 studies), Hepatitis B (8 studies), syphilis (7 studies), condyloma acuminata (3 studies), gonorrhoea (3 studies), chlamydia (3 studies) and cytomegalovirus (2 studies). In studies reporting specific STIs, those with the highest prevalence in HIV positive individuals were syphilis, gonorrhoea and chlamydia. In addition, 14 studies reported STIs being associated with HIV infection, but did not report specific STIs.
Syphilis was a common STI found in individuals with HIV infection, present in 38% of HIV infected patients in Tokyo [31] , 11% of MSM living with HIV [32] and 11% of individuals newly diagnosed with HIV in an Italian cohort study [33] . Gonorrhoea was also a common STI found in 27% of those newly diagnosed with HIV from a London HIV clinic [34] and 67 cases of gonorrhoea were reported prior to diagnosis in 1735 (3.8%) HIV infected individuals [33] . In a case control study of general practice databases in Amsterdam, gonorrhoea and syphilis were strongly associated with HIV infection OR 15.9, 95% CI 2.0 to infinity and OR 39.3 95% CI 5.7 to 1703.9 respectively [35] . [36] .
A nationwide population-based cohort study encompassing all Danish residents aged 20-60 years during a 19-year study period estimated the five-year risk of an HIV diagnosis (FYRHD) after a first-time diagnosis of 147 pre-specified potential indicator diseases [37] . The study showed that a number of diseases were identified with a FYRHD >0.1% including infectious diseases such as syphilis and hepatitis which were associated with particularly high FYRHD. Other STIs and BBVs commonly seen in individuals with HIV infection are shown in Table 1 alongside the study references.
Conditions associated with immunosuppression and cancer
The most commonly reported conditions associated with immunosuppression and cancers in individuals with HIV infection were; pneumonia (24 studies), oral/oesophageal candidiasis (14 studies), Kaposi sarcoma (8 studies), cervical dysplasia and cervical cancer (7 studies), lymphoma and Non-Hodgkins Lymphoma (NHL) (4 studies) and wasting syndrome (3 studies).
Pneumonia was a common condition associated with immunosuppression found in HIV infected individuals. Bacterial pneumonia was reported in 4% of HIV infected patients in a retrospective case note review in primary and secondary care settings [38] and in 8% of patients in a service evaluation of four general practices in London [39] . In a UK case control study of patients in general practices that used data from the health improvement network (THIN) database bacterial pneumonia and oral candidiasis were most strongly associated with HIV infection (OR 47.7, 95% CI 5.6 to 404.2 and OR 29.4 95% CI 6.9 to 125.5, respectively) [40] . The percentage prevalence of pneumocystis jiroveci pneumonia (PJP) in HIV infected individuals across primary, secondary and tertiary care settings ranged from 9 to 29% ( Fig. 1 ) with the highest prevalence in secondary care settings estimated from two separate studies of newly HIV infected individuals from retrospective reviews of patient medical records [20, 41] .
Kaposi sarcoma (Fig. 2 ) was a common cancer associated with immunosuppression seen among HIV positive patients in primary care [39] , secondary care [31, 42, 43] , secondary and tertiary setting [44, 45] and across all 3 settings [46] .
Oral /oesophageal candidiasis and wasting syndrome were also frequently reported conditions seen either prior to or after an HIV positive diagnosis. A large retrospective study of newly infected adults in Sweden found candida oesophagitis and wasting syndrome to be the most common AIDS defining conditions [17] . In HIV infected late presenters (presenting with AIDS defining illness and/or CD4 counts of <350 cells/µl) in Germany, 51% reported symptoms of candida oesophagitis and 40% with wasting syndrome [20] . Oral candidiasis was reported as a common condition in 4 studies [35, 39, 47, 48] and oesophageal candidiasis in 5 studies [31, 47, [49] [50] [51] . 
Other common conditions & symptoms
Other conditions and symptoms commonly reported were blood dyscrasias with prevalence in HIV infected individuals of 5% in primary care [39] , 4% in primary and secondary care [38] and 6.4% in tertiary care [52] . Specifically, thrombocytopenia was a common blood disorder reported in HIV infected individuals across all settings [20, 31, 36, 44, 53, 54] . The prevalence of seborrhoeic dermatitis in HIV infected individuals ranged from 1% to 2.7% in primary care [35, 39] , 4.2% in secondary care [47] and 2.1% [33] and 2.6% [48] in tertiary care (Fig. 3) . Herpes zoster was also commonly reported in HIV positive patients, with a prevalence of 6.9% in a primary care study [35] , 1.3% [31] ,9% [20] and 5.5% [47] in secondary care settings and 4.6% in a tertiary care setting [48] (Fig. 4) .
Tuberculosis or pulmonary tuberculosis were observed in 5 studies investigating HIV ICs in HIV positive patients, with prevalence ranging from 0.6% to 5.5% across different healthcare settings ( Fig. 5 ). Weight loss and diarrhoea were also very common symptoms and reported in many studies investigating HIV ICs in HIV positive patients prior to or after diagnosis. The Setting & Study Reference prevalence of weight loss ranged from 1.3 to 8.8% (not including individuals with PHI/AHI) ( Fig. 6) with the highest prevalence observed in a case control study in Amsterdam from a general practice database showing a strong association with HIV infection (OR 39, 95% CI 2.0 to infinity) [35] . In addition, the THIN study showed a strong association between weight loss and HIVinfection (OR 13.4, 95% CI 5.0 to 36) [40] .
Fig. 3. Prevalence of seborrheic dermatitis in HIV+ individuals across different healthcare settings
Prevalence of diarrhoea in HIV infected individuals ranged from 1% to 9% (Fig. 7) with the highest prevalence observed in tertiary care settings of newly diagnosed HIV patients, from retrospective audits of HIV centres in the UK [52] and from a French national agency for research on AIDS and viral hepatitis cohort (ANRS) [14] .
The nationwide population study of Danish residents estimating FYRHD after a first-time diagnosis of 147 HIV ICs [37] found that endocarditis, several pulmonary vascular diseases and haematological diseases (particularly in males) (e.g thrombocytopenia) were also associated with an FYRHD >0.1%. Gastrointestinal disease in older males, and 
Prevalence of Tuberculosis
Setting & Study Reference facial nerve disorder and neuropathy in males were associated with an FYRHD >0.1%.
Interventions Using HIV ICs to Guide HIV Testing and Case Finding
Characteristics of the studies
We found 12 intervention studies that had used HIV ICs as markers or flags either in isolation or alongside other risk factors to guide HIV testing and case finding ( Articles describing studies included ten peer reviewed papers and two abstracts from BHIVA conference proceedings (n=2). Locations of included studies were as follows; within Europe including the UK (n=2), Spain (n=3), Belgium 
Fig. 6. Prevalence of weight loss in HIV+ individuals across different healthcare settings
Effectiveness of Interventions using HIV ICs to guide HIV testing
The majority of studies showed that interventions using HIV ICs to guide testing were successful in increasing testing rates and the number of HIV positives identified ( [57] . A later evaluation study found that the impact on HIV testing rates was fully sustainable and that providers became more proficient at offering and discussing HIV tests [58] .
Branch et al., carried out a study to assess the feasibility and acceptability of an electronic clinical decision support system prompting HIV testing for use in hospital and general practice. An algorithm was devised so that when certain tests were selected (e.g hepatitis serology) a screen prompt would suggest also offering an HIV test. Evaluation interviews with the doctors and nurses conducted after a 3-month trial period found that the prompt was generally acceptable and was considered useful and educational. Nurses reported that they were less comfortable responding to the prompt in situations where they thought testing was not justified. However, only between 1% and 2% of all prompts were accepted by the HCP. No positive HIV tests resulted from the prompts, but the number of tests ordered increased by 6% in the primary care setting compared to the previous 9 months before the trial (p=0.165). This study is currently being developed further to refine the application to provide more accurate risk stratification [59] . Objective: to analyse whether a collaboration to raise awareness of the importance of early detection of HIV in 3 primary care centres influenced the proportion of HIV serology requested. Outcome: Predictors of HIV request were having an IC in 2012, a younger age, having a mononucleosis syndrome and not being Spanish. The HIV request demand tripled after the collaboration with primary care centres, however in 88% of patients the test was not requested, resulting in diagnostic losses. Addition of a clinical reminder to the electronic medical record increased the amount of testing for HIV by 369%. 24 were diagnosed as HIV+ Objective: to assess effectiveness of an electronic clinical reminder added to medical records within the Veterans Affairs (VA) healthcare system (based on risk factors for HIV: Hepatitis, STDs, high risk sexual behaviour, alcohol or substance use disorders). Outcome: Testing led to the diagnosis of HIV in 24 patients over a 19-month period and were able to increase testing by 369%. The reminder was highly effective in those aged 64yrs or less but less evidence that it was effective for increasing HIV detection in those aged 65 or more. Schrantz et al 2011 [56] [62] .
Reference & Study location
Two studies used more targeted approaches to HIV testing using preselected ICs [24, 63] . Elias and colleagues developed an HIV risk exposure and ICs questionnaire using 14 preselected ICs to support targeted screening. The study found that the self-completed questionnaire was feasible and accurately discriminated all non-HIV infected people without missing any HIV diagnoses in a low prevalence area [63] . In primary care settings in Spain, Menacho et al. prospectively compared IC guided testing using 4 preselected ICs (herpes zoster, seborrhoeic eczema, mononucleosis syndrome and leukopenia/ thrombocytopenia) with random testing using rapid finger stick tests. The study found using ICs was a feasible and less expensive way to improve diagnosis of HIV infection compared with a non-targeted approach [24] .
We also identified a number of studies that developed risk prediction tools to identify individuals at risk of HIV infection based on HIV ICs and other risk factors [64] [65] [66] . HIV ICs used for these risk predictions tools mainly incorporated history of fever, STIs and STDs (included chlamydia, gonorrhoea and syphilis). Other behavioural risk factors incorporated in the tools included sexual behaviour/practices, number of sexual partners, PWID and substance use. These prediction models were successful in accurately categorising patients at increasing probabilities of infection [64, 66] and risk scores were predictive of HIV acquisition in MSM [65] .
DISCUSSION
Increasing HIV testing is crucial for identifying individuals who remain undiagnosed and linking them to care and treatment with ART. This is important for their own health and because treatment with ART substantially reduces risk of further transmission of the virus [67] . In the USA, the current guidance is for routine testing among all adults that come into contact with the healthcare system [11] but this is thought not to be best practice for the majority of European settings due to the poor cost-benefit ratio in certain areas where prevalence of HIV is low [68] . In the UK and Europe, HIV testing is recommended for individuals presenting with ICs associated with HIV infection [19, 21] . The HIV in Europe initiative states that HIV testing of any person presenting with a condition associated with an undiagnosed HIV prevalence of >0.1% is cost-effective and promotes earlier diagnosis of HIV infection [21] . In the UK the 2008 BHIVA guidelines [10] were published with the aim of increasing HIV testing across healthcare settings to reduce the number of individuals with undiagnosed HIV infection. Routine testing in the UK is recommended in areas with > 2 per 1000 population prevalence based on cost effectiveness studies of HIV testing in the USA and France [69] [70] [71] . Regardless of local prevalence, testing should be offered to those presenting with any HIV ICs and/or other risk factors [10] . However, studies and reviews have shown there is a general lack of awareness and knowledge of the 2008 guidelines by HCPs [72] [73] [74] . Previous reviews and audits [75, 76] show that adherence and application of these guidelines is poor, during the eight years after their publication, mainly due to limited test offer and lack of knowledge of HIV ICs by the HCP [75, [77] [78] [79] .
In this review, we have drawn together the most common HIV ICs and diseases that are most frequently seen in HIV infected individuals prior to or after receiving an HIV diagnosis. The most common ICs identified in those with PHI /AHI were fever/pyrexia of unknown origin [25] [26] [27] 29, 30] , lymphadenopathy [25] [26] [27] [28] , headache [25] [26] [27] 29] , rash [25] [26] [27] 29, 30] , weight loss [25, [27] [28] [29] , and gastrointestinal symptoms (nausea, vomiting, and diarrhoea) [25] [26] [27] [28] [29] . The strongest associations with HIV infection were seen for weight loss, vomiting, lymphadenopathy, fever and rash [28, 30] . The most commonly reported STIs and BBVs in HIV infected individuals (either prior to or after diagnosis) were hepatitis C [22, 23, 33, 34, 44, 47, 54, 80, 81] , hepatitis B [22, 23, 31, 33, 35, 44, 47, 54] , syphilis [31, [33] [34] [35] [36] [37] 80] , chlamydia [34, 35, 45] , gonorrhoea [33] [34] [35] , condyloma acuminate [31, 35, 37] , cytomegalovirus [31, 49] and genital herpes [33, 35] . The strongest associations with HIV infection were seen for syphilis, gonorrhoea, hepatitis B/C and condyloma acuminata. The most common conditions associated with immunosuppression in individuals with HIV infection were pneumonia [17,20,31,35,37-46, 48-51,53,54,81-84] , oral/oesophageal candidiasis [17, 20, 23, 31, 35, 39, 40, 42, 44, 47, [49] [50] [51] 83] , Kaposi sarcoma [31, 39, [42] [43] [44] [45] [46] , lymphoma and non-Hodgkins lymphoma (NHL) [22, 23, 31, 43] , wasting syndrome [17, 20, 42] and cervical dysplasia/cervical cancer [17, 20, 22, 23, 35, 45, 47] . The conditions most strongly associated with immunosuppression were pneumonia, (incl, pneumocystis jiroveci pneumonia and bacterial pneumonia), oral candidiasis/candida oesophagitis, wasting syndrome and cytomegalovirus.
Interventions that incorporate HIV IC guided testing are especially warranted in areas of low HIV prevalence where HCPs are less familiar with HIV testing. Indeed, Chadwick et al. reported that a clinical decision support system (CDSS) prompt acted as a useful reminder for GPs to offer an HIV test in a low prevalence area (<0.5%) and was shown to have significant potential to increase HIV testing in such areas [85] . This review shows that HIV ICs have the potential to be used more effectively to guide HIV testing. Evidence from numerous studies have shown that had testing been offered to those presenting with an HIV IC, a high proportion of individuals between 21% and 37% [17, 20] would have received a much earlier diagnosis. A study reviewing medical encounters before HIV diagnosis in the USA revealed that increased recognition of ICs for HIV testing prompted earlier HIV diagnosis in 22% of individuals [48] . Approximately 30% of newly diagnosed adults with HIV infection reported at least one IC before HIV diagnosis and that being tested for HIV within 6 months of being diagnosed with an IC reduced risk of late HIV presentation by 50% [33] . Results from the HIDES I and II studies [22, 23] showed that patients with preselected indicator diseases had an HIV prevalence of >0.1%, providing firm evidence that IC guided testing provides a valuable opportunity to identify individuals with HIV infection.
In the UK, the National Institute for Health Care Excellence (NICE) have recently produced a draft quality standard document [9] (https://www.nice.org.uk/guidance/GID-QS10040/documents/draft-quality-standard) to encourage uptake of HIV testing which is due to be published in August 2017. It discusses interventions to improve the uptake of HIV testing among adults and young people that may have undiagnosed infection. This document has produced a list of HIV ICs which should be prioritised from the longer list identified by HIV in Europe Initiative. One of 6 questions open to consultation is 'We have identified indicator conditions that could be a priority for local measurement from the longer list of indicator conditions identified by HIV in Europe. Will it be practical to implement this?'. The list includes HIV ICs that service providers may wish to focus on as priorities, feedback from this document will be useful to aid any future interventions to improve uptake of HIV testing. Prioritising and focusing on HIV ICs that commonly present themselves could better inform testing strategies to identify HIV infected patients. Indeed, work is in progress to update guidelines for specialities other than HIV, such as dermatology or cancer, for the management of HIV ICs and AIDS defining conditions (ADCs), with a recent study showing that HIV testing was only recommended in 6 out of 17 guidelines for treating conditions that are also ADCs (35%) and 24 of 61 guidelines for treating conditions that are also HIV ICs (39%) [86] .
The studies on common HIV ICs and diseases reviewed here provide information on using them as important indicators of potential underlying HIV infection, which could be used within prediction tools to flag that an HIV test should be offered, giving a more targeted approach to testing. Computer prompts avoid the HCP having to make a personal judgment on the risk of HIV and provides a platform for discussing having an HIV test, based on a prediction model ,which addresses some of the barriers to testing that are commonly reported by HCPs [74] . Interventions that have used ICs as a guide to testing (as well as other risk factors for HIV) alongside provider education sessions to improve awareness of HIV ICs are more effective in increasing HIV testing rates than education alone. Education and training of HCPs needs to continue and should focus on HIV ICs most likely to be encountered in primary care to help reduce incidence of late diagnosis. Strategies or interventions that empower or prompt GPs to test and enhance awareness of the national guidelines for IC HIV testing may help to find those with undiagnosed infection and reduce late diagnosis of HIV.
LIMITATIONS
This review is not a full review as it only includes grey literature from BHIVA conference proceedings (2010 to 2017) and articles included in the review are those that have encompassed the search term keywords outlined in the methods section (found within the article title, keywords or abstract). Therefore, some relevant articles may not be included. However, further articles were found by hand searching article reference lists. Comparing studies in this review should be interpreted with caution due to the different HIV testing guidelines, methodologies used to collect the data and possible differences in condition/disease prevalence between and within countries.
CONCLUSIONS AND RECOMMENDA-TIONS
This review provides a summary of important information for early detection strategies so that HIV infected individuals can receive a timely HIV test. Increased awareness of HIV infection within the primary care setting is paramount and could be improved by using computer prompts/reminders based on common HIV ICs to aid the HCP in appropriate offering of an HIV test. More targeted testing for HIV based on diagnosis of an HIV IC is an important strategy which has been shown to be effective and could potentially help reduce onward transmission and help control the HIV epidemic.
